A Prospective descriptive one-year study in France of all BCG therapy dispensations for NMIBC.

Yann NeuzilletPriscilla LeonThomas SeisenYves AlloryFrancois AudenetYohann LoriotAlexandra Masson-LecomteArnaud MejeanBenjamin PradèreMathieu Roumiguié Olivier TraxerEvanguelos XylinasGeorges FournierMorgan Roupret

Published in: BJU international (2022)

Our data suggest that the incidence of NMIBC at high-risk of recurrence and progression is underestimated in reference epidemiological studies. These results should help to better define future care needs.

Keyphrases

muscle invasive bladder cancer
healthcare
palliative care
risk factors
quality improvement
stem cells
big data
pain management
free survival
machine learning
mesenchymal stem cells
artificial intelligence
case control